Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!

Daniel R. van Langenberg; Abhinav Vasudevan

doi:10.1111/apt.14959

Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!

Daniel R. van Langenberg, Abhinav Vasudevan

Eastern Health Clinical School

Research output: Contribution to journal › Letter › Other › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1028-1029
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	48
Issue number	9
DOIs	https://doi.org/10.1111/apt.14959
Publication status	Published - 1 Nov 2018

Access to Document

10.1111/apt.14959

Cite this

@article{1b40af1e84224f6f93fb9d707e68d698,

title = "Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!",

author = "{van Langenberg}, {Daniel R.} and Abhinav Vasudevan",

year = "2018",

month = nov,

day = "1",

doi = "10.1111/apt.14959",

language = "English",

volume = "48",

pages = "1028--1029",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Letter

T2 - overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!

AU - van Langenberg, Daniel R.

AU - Vasudevan, Abhinav

PY - 2018/11/1

Y1 - 2018/11/1

UR - http://www.scopus.com/inward/record.url?scp=85054681805&partnerID=8YFLogxK

U2 - 10.1111/apt.14959

DO - 10.1111/apt.14959

M3 - Letter

C2 - 30318695

AN - SCOPUS:85054681805

SN - 0269-2813

VL - 48

SP - 1028

EP - 1029

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 9

ER -

Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!

Access to Document

Other files and links

Cite this